Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

NCT00100009 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: TAC-PF
DRUG: Triamcinolone Acetonide

Sponsor

National Eye Institute (NEI)